Resmed Q4 Adjusted EPS USD 2.95 Vs. IBES Estimate USD 2.89
RMD•Resmed reports fourth-quarter results
Aug. 6 (Reuters) - Resmed Q4 revenue was USD 1,500 million versus the IBES estimate of USD 1,459 million.
- Q4 EPS: USD 2.64
- Q4 adjusted gross margin: 62.3%
